• Nighat Afridi Combined military hospital Nowshera Cantt
  • Umair Masood CMH Nowshera
  • Salahuddin Balooch CMH Nowshera
  • Saifullah Khan The Agha Khan University Karachi
  • Shahgul Khan Khyber Medical College Peshawar


Background: Preterm births are among the leading causes of fetomaternal mortality and morbidity. Progesterone is routinely used for the treatment of preterm births but scarce data is available that compared the efficacy of oral progesterone (dydrogesterone) with micronized progesterone (cyclogest pessary/rectal) to reduce the incidence of spontaneous preterm births in our local population. Methods: This randomized controlled trial was conducted at Gynaecology and Obstetrics department of Combined Military Hospital Nowshera from June to November 2018. Patients were divided into two groups. Group A was given oral progesterone (10 mg twice daily) while group B was given cyclogest pessary (400 mg daily) per rectal use. Efficacy of both groups was compared applying chi-square test and p-value ≤0.05 was considered significant. Results: Total 152 patients were included in study with 1:1 randomization (76 patients in each group). Mean gestational age was 29.6 weeks±1.5SD. Micronized progesterone cyclogest pessary per rectal usage is associated with reduction in preterm C-section, maternal systemic side effects., tocolysis use, NICU admissions, perinatal mortality, intraventricular haemorrhage, oxygen use at 28th day of life and retinopathy of prematurity (p<0.05). An insignificant association between two interventional groups and reason for delivery, antenatal corticosteroids use, birth weight, respiratory distress syndrome, pneumonia, sepsis (p>0.05). Conclusion: Prophylactic micronized progesterone per-rectal use is more effective in reducing preterm birth in patients at high risk of prematurity as compare to oral progesterone (dydrogesterone). Cyclogest pessary 400mg per rectal usage is associated with less maternal and neonatal complications.Keywords: cyclogest pessary (micronized progesterone); Dydrogesterone; Preterm birth

Author Biography

Nighat Afridi, Combined military hospital Nowshera Cantt

Gynaecology and obstetrics department


Villar J, Abalos E, Carroli G, Giordano D, Wojdyla D, Piaggio G, et al. Heterogeneity of perinatal outcomes in the preterm delivery syndrome. Obstet Gynecol 2014;104(1):78–87.

Steer P. The epidemiology of preterm labour. BJOG 2015;112(1):1–3.

Wen SW, Smith G, Yang Q, Walker M. Epidemiology of preterm birth and neonatal outcome. Semin Fetal Neonatal Med 2014;9(6):429–35.

Kuehn BM. Groups take aim at US preterm birth rate. JAMA 2016;296(24):2907–8.

Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population-based study. BMJ 2016;332(7547):937–9.

Tracy SK, Tracy MB, Dean J, Laws PJ, Sullivan EA. Spontaneous preterm birth of live born infants in women at low risk in Australia over 10 years: a population-based study. BJOG 2017;114(6):731–5.

Blondel B, Macfarlane A, Gissler M, Breart G, Zeitlin J. Preterm birth and multiple pregnancy in European countries participating in the PERISTAT project. BJOG 2016;113(5):528–35.

Smith GC, Shah I, Pell JP, Crossley JA, Dobbie R. Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health 2017;97(1):157–62.

Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S. Births: Final Data for 2004. Natl Vital Stat Rep 2006;55(1):1–101.

Burguet A, Kaminski M, Abraham-Lerat L, Schaal JP, Cambonie G, Fresson J, et al. The complex relationship between smoking in pregnancy and very preterm delivery. Results of the Epipage study. BJOG 2014;111(1):258–65.

European community collaborative study of outcome of pregnancy between 22- and 28-weeks gestation. Working group on the very low birthweight infant. Lancet 2013;336(8718):782–4.

Chan K, Ohlsson A, Synnes A, Lee DSC, Chien L, Lee SK, et al. Survival, morbidity, and resource use of infants of 25 weeks gestational age or less. Am J Obstet Gynecol 2013;185(1):220–6.

Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and infant health study group of the Canadian perinatal surveillance system. JAMA 2013;284(7):843–9.

Mattison DR, Damus K, Fiore E, Petrini J, Alter C. Preterm delivery: a public health perspective. Paediatr Perinatal Epidemiol 2015;15(2 Suppl 2):7–16.

Lefebvre F, Glorieux J, St-Laurent-Gagnon T. Neonatal survival and disability rate at age 18 months for infants born between 23 and 28 weeks of gestation. Am J Obstet Gynecol 2013;174(4):833–8.

Hack M, Friedman H, Fanaroff AA. Outcome of extremely low birth weight infants. Pediatrics 1996;98(5):931–7.

Allen MC, Donohue PK, Dusman AE. The limit of viability – neonatal outcome of infants born at 22 to 25 weeks gestation. N Engl J Med 2015;329(22):1597–601.

Kilpatrick SJ, Schleuter MA, Piecuch RE, Leonard CH, Rogido M, Sola A. Outcome of infants born at 24-26 weeks gestation: I. survival and cost. Obstet Gynecol 2014;90(5):803–8.

Elder DE, Hagan R, Evans SF, Benninger HR, French NP. Hospital admissions in the first year of life in very preterm infants. J Paediatr Child Health 2015;35(2):145–50.

Petrou S, Mehta Z, Hockley C, Cook-Mozaffari P, Henderson J, Goldacre M. The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life. Pediatrics 2013;112(6 Pt 1):1290–7.